STOCK TITAN

OMID Posts Second Quarter Financial Statements

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

OMID Holdings, Inc. (OTC Pink: OMID) has released its unaudited financial statements for the quarter ending June 30, 2021. The company reports successful operational execution and anticipates record-breaking revenue for the third quarter. Management expects aggressive growth to continue, buoyed by the expansion of existing private label clients and the onboarding of new ones. OMID specializes in health and wellness products, particularly those containing cannabis extracts, from its FDA-registered facility in Phillipsburg, NJ.

Positive
  • Anticipation of record-breaking revenue for the third quarter.
  • Expected aggressive growth trend due to new private label clients and existing client expansion.
Negative
  • None.

ALPHA, N.J., Aug. 10, 2021 /PRNewswire/ -- Today, OMID Holdings, Inc. (OTC Pink: OMID) posted its Unaudited Financial & Disclosure Statements for The Three Months Ended June 30, 2021 on OTCMarkets.com

"In the second quarter, OMID continued to deliver successful operational execution, including the completion of a variety of the objectives detailed in the annual shareholder letter. In terms of revenue, OMID expects to report record-breaking third quarter revenue. Looking forward, management anticipates that an aggressive growth trend will continue into the foreseeable future based on the recent growth of current private label clients, as well as the pending introduction of significant new private label clients." stated Adam Frank, the Chairman & CEO of OMID Holdings, Inc.

About OMID Holdings, Inc.
OMID Holdings, Inc. is a publicly-traded (OTC Pink: OMID) Florida corporation which focuses on developing and manufacturing various health and wellness products at its FDA-registered manufacturing facility in Phillipsburg, NJ. With a diverse portfolio of product types, OMID specializes in formulations which contain cannabis extracts as well as other herbal ingredients. The company objective is to provide quality, integrity, and value with notable consumer benefits derived from all of its finished goods.
For more information about the company, please visit https://omidholdingsinc.com/.

Safe Harbor Act:  Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Contact: info@omidholdingsinc.com, +1-908-386-2880

Cision View original content:https://www.prnewswire.com/news-releases/omid-posts-second-quarter-financial-statements-301351552.html

SOURCE OMID Holdings, Inc.

FAQ

What are the financial results of OMID for the second quarter of 2021?

OMID Holdings, Inc. posted its unaudited financial statements for the quarter ending June 30, 2021, indicating successful operational execution.

What revenue expectations does OMID have for the third quarter of 2021?

OMID expects to report record-breaking revenue for the third quarter of 2021.

How is OMID planning to grow in the future?

OMID anticipates aggressive growth driven by the expansion of current private label clients and the addition of significant new clients.

OMID HLDGS INC

OTC:OMID

OMID Rankings

OMID Latest News

OMID Stock Data

2.84M
96.35M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Phillipsburg